Morning Overview on MSN
UCLA develops low-cost blood test to flag multiple cancers and diseases
Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers ...
Detection Market · GlobeNewswire Inc. The cell-free tumor DNA detection market is set to experience significant growth, ...
MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...
April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...
Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients for ...
Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
DEAR DR. ROACH: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? -- M.N. ANSWER: When screening patients ...
Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? — M.N. The agency provided gross pay records ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results